✦ LIBER ✦

63 Navelbine (NVB), and fractionated doses of cisplatin (CDDP) — 20 mg/m2/5 days — in the management of advanced non-small cell lung cancer: An overview of 3 phase II trials

✍ Scribed by Rodrigues, J.; Pawlicki, M.; Firat, D.; Altino, J.; Krawczyk, K.; Barista, ; Le Bras, F.; Burillon, J.P.; Delgado, F.M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An overview of 3 phase II trials of nave

✍ Pawlicki, M.; Rodrigues, J.; Firat, D.; Altino, J.; Krawczyk, K.; Le Bras, Baris 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 265 KB

158 Phase II study of navelbine (NVB) an

✍ Murad, A.; Rodrigues, J.; Malzyner, A.; Caponero, R.; Yamaguchi, N.; Altino, J.; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 158 KB

A phase I-II trial of cisplatin (CDDP),

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 180 KB